|
1
|
Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.
|
J Physiol
|
2009
|
2.64
|
|
2
|
Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging.
|
J Appl Physiol (1985)
|
2008
|
2.20
|
|
3
|
Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling.
|
J Appl Physiol (1985)
|
2009
|
1.65
|
|
4
|
Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids.
|
J Nutr
|
2011
|
1.60
|
|
5
|
Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women.
|
J Nutr
|
2010
|
1.51
|
|
6
|
An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle.
|
Am J Physiol Endocrinol Metab
|
2010
|
1.48
|
|
7
|
Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids.
|
Am J Physiol Endocrinol Metab
|
2008
|
1.45
|
|
8
|
Bed rest impairs skeletal muscle amino acid transporter expression, mTORC1 signaling, and protein synthesis in response to essential amino acids in older adults.
|
Am J Physiol Endocrinol Metab
|
2012
|
1.41
|
|
9
|
Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy.
|
Am J Physiol Cell Physiol
|
2012
|
1.29
|
|
10
|
Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelial-dependent vasodilation and mammalian target of rapamycin complex 1 signaling.
|
J Clin Endocrinol Metab
|
2010
|
1.24
|
|
11
|
Muscle protein breakdown has a minor role in the protein anabolic response to essential amino acid and carbohydrate intake following resistance exercise.
|
Am J Physiol Regul Integr Comp Physiol
|
2010
|
1.20
|
|
12
|
Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle.
|
J Nutr
|
2009
|
1.20
|
|
13
|
Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults.
|
Diabetes
|
2010
|
1.13
|
|
14
|
Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise.
|
J Appl Physiol (1985)
|
2011
|
1.11
|
|
15
|
Reactive hyperemia is not responsible for stimulating muscle protein synthesis following blood flow restriction exercise.
|
J Appl Physiol (1985)
|
2012
|
1.06
|
|
16
|
A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults.
|
Am J Clin Nutr
|
2012
|
1.06
|
|
17
|
Exercise, amino acids, and aging in the control of human muscle protein synthesis.
|
Med Sci Sports Exerc
|
2011
|
1.00
|
|
18
|
Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
|
J Appl Physiol (1985)
|
2007
|
1.00
|
|
19
|
Protein blend ingestion following resistance exercise promotes human muscle protein synthesis.
|
J Nutr
|
2013
|
0.97
|
|
20
|
Automated fiber-type-specific cross-sectional area assessment and myonuclei counting in skeletal muscle.
|
J Appl Physiol (1985)
|
2013
|
0.90
|
|
21
|
Addition of carbohydrate or alanine to an essential amino acid mixture does not enhance human skeletal muscle protein anabolism.
|
J Nutr
|
2013
|
0.87
|
|
22
|
PAX7+ satellite cells in young and older adults following resistance exercise.
|
Muscle Nerve
|
2012
|
0.85
|
|
23
|
Rapamycin does not affect post-absorptive protein metabolism in human skeletal muscle.
|
Metabolism
|
2012
|
0.83
|
|
24
|
Protein Supplementation Does Not Affect Myogenic Adaptations to Resistance Training.
|
Med Sci Sports Exerc
|
2017
|
0.75
|
|
25
|
Altered satellite cell dynamics accompany skeletal muscle atrophy during chronic illness, disuse, and aging.
|
Curr Opin Clin Nutr Metab Care
|
2017
|
0.75
|